↓ Skip to main content

Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
39 X users
patent
4 patents
wikipedia
13 Wikipedia pages

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
161 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies
Published in
Orphanet Journal of Rare Diseases, May 2020
DOI 10.1186/s13023-020-01379-8
Pubmed ID
Authors

Thomas Opladen, Eduardo López-Laso, Elisenda Cortès-Saladelafont, Toni S. Pearson, H. Serap Sivri, Yilmaz Yildiz, Birgit Assmann, Manju A. Kurian, Vincenzo Leuzzi, Simon Heales, Simon Pope, Francesco Porta, Angeles García-Cazorla, Tomáš Honzík, Roser Pons, Luc Regal, Helly Goez, Rafael Artuch, Georg F. Hoffmann, Gabriella Horvath, Beat Thöny, Sabine Scholl-Bürgi, Alberto Burlina, Marcel M. Verbeek, Mario Mastrangelo, Jennifer Friedman, Tessa Wassenberg, Kathrin Jeltsch, Jan Kulhánek, Oya Kuseyri Hübschmann

X Demographics

X Demographics

The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 161 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 14%
Researcher 21 13%
Student > Bachelor 16 10%
Student > Master 11 7%
Other 8 5%
Other 25 16%
Unknown 57 35%
Readers by discipline Count As %
Medicine and Dentistry 30 19%
Biochemistry, Genetics and Molecular Biology 21 13%
Neuroscience 13 8%
Agricultural and Biological Sciences 7 4%
Nursing and Health Professions 6 4%
Other 23 14%
Unknown 61 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2024.
All research outputs
#1,201,626
of 25,927,633 outputs
Outputs from Orphanet Journal of Rare Diseases
#125
of 3,212 outputs
Outputs of similar age
#34,948
of 431,790 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 56 outputs
Altmetric has tracked 25,927,633 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,212 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,790 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.